Breast cancer screening in germline mutation carriers. A literature review
Authors:
- A. V. SultanbaevASA. V. Sultanbaev
- A. F. NasretdinovANA. F. Nasretdinov
- M. G. GaleevMGM. G. Galeev
- K. V. MenshikovKMK. V. Menshikov
- Sh. I. MusinSMSh. I. Musin
- N. I. SultanbaevaNSN. I. Sultanbaeva
- R. T. AyupovRAR. T. Ayupov
- R. R. RakhimovRRR. R. Rakhimov
- O. N. LipatovOLO. N. Lipatov
- I. A. MenshikovaIMI. A. Menshikova
- G. A. SerebrennikovGSG. A. Serebrennikov
Open Access
- 5 August 2023
- journal article
- review article
- Published by Publishing House ABV Press in Tumors of female reproductive system
- Vol. 19 (2) , 16-24
Abstract
Carriers of germline mutations have an increased risk of developing malignant neoplasms. Mutations in the BRCA1/2 gene are the most studied, leading to an increased risk of breast cancer, characterized by early manifestation and aggressive course. The development of screening measures aimed at identifying tumors characteristic of certain mutations will increase the patient’s chances for radical treatment, and therefore lower costs for the treatment of advanced forms of malignant neoplasms. It is important to know the correlation of mutations with the characteristics of their clinical manifestation, the study of this issue will lead to the formation of a medical and economic justification for additional diagnostic procedures.Keywords
This publication has 44 references indexed in Scilit:
- Magnetic resonance imaging of the breast: Recommendations from the EUSOMA working groupEuropean Journal of Cancer, 2010
- Does family history predict the age at onset of new breast cancers in BRCA1 and BRCA2 mutation‐positive families?Clinical Genetics, 2010
- Breast cancer risk in women who fulfill high-risk criteria: at what age should surveillance start?Breast Cancer Research and Treatment, 2009
- Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation CarriersJNCI: Journal of the National Cancer Institute, 2009
- The Average Cumulative Risks of Breast and Ovarian Cancer for Carriers of Mutations in BRCA1 and BRCA2 Attending Genetic Counseling Units in SpainClinical Cancer Research, 2008
- Breast MRI: guidelines from the European Society of Breast ImagingEuropean Radiology, 2008
- Meta-Analysis of BRCA1 and BRCA2 PenetranceJournal of Clinical Oncology, 2007
- Mammographic Density and the Risk and Detection of Breast CancerNew England Journal of Medicine, 2007
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer FamiliesThe American Journal of Human Genetics, 1998